Treatment of spinal cord injury
AssigneeUniversity of Louisville Research Foundation, Inc.
InventorGirish Kotwal
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment of spinal cord injury with a vaccinia virus complement control protein (VCP).
Claims18
A method for treating a patient having a spinal cord injury, comprising administering to the patient an effective amount of Poxvirus-encoded complement inhibiting protein and a pharmaceutically-acceptable carrier, wherein the effective amount of the Poxvirus-encoded complement inhibiting protein treats at least one symptom associated with the spinal cord injury.
A method for treating a patient having a spinal cord injury, comprising administering to the patient an effective amount of Poxvirus-encoded complement inhibiting protein and a pharmaceutically-acceptable carrier, wherein the Poxvirus-encoded complement inhibiting protein is selected from the group consisting of VCP, IMP, monkeypox complement inhibiting protein, smallpox complement inhibiting protein, and variola virus complement inhibiting protein, wherein the effective amount of the Poxvirus-encoded complement inhibiting protein treats at least one symptom associated with the spinal cord injury.
Dependencies are inferred from the claim text.